Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation

Published:2019-09-03 Issue:6 Volume:55 Page:1191-1193
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Rautenberg Christina,Kaivers Jennifer,Germing Ulrich,Haas Rainer,Ackerstaff Stefanie,Hoffmann Till,Kobbe Guido,Schroeder Thomas

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0664-4.pdf

Reference7 articles.

1. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood. 2001;98:1687–94.

2. Worel N. ABO-mismatched allogeneic hematopoietic stem cell transplantation. Transfus Med Hemotherapy. 2016;43:3–12.

3. Veelken H, Wäsch R, Behringer D, Bertz H, Finke J. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant. 2000;26:911–5.

4. Aung FM, Lichtiger B, Bassett R, Liu P, Alousi A, Bashier Q, et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol. 2013;160:798–805.

5. Bathini S, Holtzman NG, Koka R, Singh Z, Wilding E, Zou Y, et al. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab. Am J Hematol. 2019. https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25515

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26

2. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

3. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

4. Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC;Bone Marrow Transplantation;2024-03-09

5. Transfusion Support During Hematopoietic Cell Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3